― FDA approves Cipher’s Absorica to treat severe recalcitrant nodular acne: Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin (left structure), for the treatment of severe recalcitrant nodular acne.Medicinal Chemistry .
+8 more likes
I am really happy to share an interesting and important article 'the secret of lowering ...
NovaBay Pharmaceuticals, Inc. recently announced that, it is will be presenting the ...
We know the that, black pepper has many medicinal benefits, like curing illness such as ...
In continuation of my update on tuberculosis and drug discovery ..... A new research ...
I had every intention of posting this week's Menu Plan when I got home from my high school ...
Dulu ∙ di kantor tempat penulis kerja it ada website perusahaan yang kita ∙ ...
Depending on the age and personality of your kids, they’ll either be really ...
